ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.409,76
-1,39%
S&P 500
6.002,41
-0,63%
Dow Jones
44.479,51
-0,15%
Euro vs US Dollar
1,03115
0,62%
Bitcoin
99.000,16
1,33%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. BriaCell Therapeutics Corporation (BCTXW)

  7. BriaCell Therapeutics Corporation (BCTXW) News

BCTXW

BriaCell Therapeutics (BCTXW)

BriaCell Therapeutics Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:BCTXW
DatumZeitQuelleÜberschriftSymbolFirma
03/02/202513h30GlobeNewswire Inc.BriaCell Announces Resolution of Lung Metastasis in First Patient treated with Bria-OTS™NASDAQ:BCTXWBriaCell Therapeutics Corporation
28/01/202522h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXWBriaCell Therapeutics Corporation
28/01/202500h42GlobeNewswire Inc.BriaCell Announces Completion of 15:1 Share ConsolidationNASDAQ:BCTXWBriaCell Therapeutics Corporation
17/12/202422h05GlobeNewswire Inc.BriaCell Announces Availability of Annual General Meeting Materials and Alternative Voting ProceduresNASDAQ:BCTXWBriaCell Therapeutics Corporation
17/12/202422h05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BCTXWBriaCell Therapeutics Corporation
17/12/202422h05GlobeNewswire Inc.BriaPro Therapeutics Corp. Announces Availability of Annual General Meeting Materials and Alternative Voting ProceduresNASDAQ:BCTXWBriaCell Therapeutics Corporation
16/12/202422h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BCTXWBriaCell Therapeutics Corporation
16/12/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXWBriaCell Therapeutics Corporation
13/12/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXWBriaCell Therapeutics Corporation
13/12/202422h05GlobeNewswire Inc.BriaCell Therapeutics Announces Closing of $5.5 Million Public OfferingNASDAQ:BCTXWBriaCell Therapeutics Corporation
13/12/202413h50GlobeNewswire Inc.BriaCell 2024 SABCS® Poster Highlights Ability of Bria-IMT™ Regimen to Increase Cancer-Fighting Immune Cells in Metastatic Breast CancerNASDAQ:BCTXWBriaCell Therapeutics Corporation
12/12/202423h27Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BCTXWBriaCell Therapeutics Corporation
12/12/202412h06Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:BCTXWBriaCell Therapeutics Corporation
12/12/202405h54GlobeNewswire Inc.BriaCell Therapeutics Announces Pricing of $5.5 Million Public OfferingNASDAQ:BCTXWBriaCell Therapeutics Corporation
11/12/202423h21Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BCTXWBriaCell Therapeutics Corporation
11/12/202422h05GlobeNewswire Inc.BriaCell Therapeutics Announces Proposed Public OfferingNASDAQ:BCTXWBriaCell Therapeutics Corporation
11/12/202413h50GlobeNewswire Inc.BriaCell Presents Unprecedented Overall Survival Data in Metastatic Breast Cancer in Spotlight Poster at 2024 SABCS®NASDAQ:BCTXWBriaCell Therapeutics Corporation
10/12/202412h06Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:BCTXWBriaCell Therapeutics Corporation
05/12/202413h45Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:BCTXWBriaCell Therapeutics Corporation
02/12/202413h50GlobeNewswire Inc.BriaCell Receives Green-Light from Data Safety Monitoring Board for its Phase 3 Study in Metastatic Breast CancerNASDAQ:BCTXWBriaCell Therapeutics Corporation
26/11/202413h50GlobeNewswire Inc.BriaCell 2024 SABCS® Spotlight Poster to Showcase Positive Overall Survival Data Across All Patient Subtypes in Metastatic Breast CancerNASDAQ:BCTXWBriaCell Therapeutics Corporation
25/11/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXWBriaCell Therapeutics Corporation
25/11/202413h50GlobeNewswire Inc.BriaCell Provides Update to its Board of DirectorsNASDAQ:BCTXWBriaCell Therapeutics Corporation
21/11/202413h50GlobeNewswire Inc.BriaCell Announces First Patient Dosed with Bria-OTS™ in Metastatic Breast Cancer StudyNASDAQ:BCTXWBriaCell Therapeutics Corporation
14/11/202418h17Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:BCTXWBriaCell Therapeutics Corporation
08/11/202413h50GlobeNewswire Inc.BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC ConferenceNASDAQ:BCTXWBriaCell Therapeutics Corporation
04/11/202413h50GlobeNewswire Inc.BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13NASDAQ:BCTXWBriaCell Therapeutics Corporation
01/11/202421h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXWBriaCell Therapeutics Corporation
22/10/202413h50GlobeNewswire Inc.BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival DataNASDAQ:BCTXWBriaCell Therapeutics Corporation
15/10/202413h50GlobeNewswire Inc.BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal StudyNASDAQ:BCTXWBriaCell Therapeutics Corporation
 Showing the most relevant articles for your search:NASDAQ:BCTXW

Kürzlich von Ihnen besucht

BIT
S31880
Societe Generale Effekten
BIT
SFNG
Graniteshares 1x Short F...
BIT
NSCIT9058JP5
International Bank for R...
AQSE
RCDO.GB
Ricardo
BIT
F13908
Vontobel Financial Produ...
BIT
F13007
Vontobel Financial Produ...
BIT
F21326
Vontobel Financial Produ...
BIT
P1MOY7
BNP Paribas Issuance
BIT
1GILD
Gilead Sciences
AQSE
EDVD.GB
State Street Global Advi...
BIT
UB6SQH
Unicredit Bank
BIT
UI449X
UniCredit
BIT
UI539B
Unicredit Bank
BIT
UB6DEF
Unicredit Bank
BIT
FINX
Global X Fintech UCITS E...
BIT
JAVA
ETF
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten